Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluating the Risk Factors and the Role of Albumin-to-globulin Ratio in Predicting Recurrence Among Patients With Idiopathic Granulomatous Mastitis

NCT05409586 is registered in ClinicalTrials.gov with Samsun Education and Research Hospital as lead sponsor.

NCT NCT05409586
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05409586 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluating the Risk Factors and the Role of Albumin-to-globulin Ratio in Predicting Recurrence Among Patients With Idiopathic Granulomatous Mastitis
Lead sponsor
Samsun Education and Research Hospital
Phase
Observational
Overall status
Completed
Start date
April 20, 2022
Completion date
May 25, 2022
Enrollment
109 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

idiopathic granulomatous mastitis